Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
222.08
-4.58 (-2.02%)
At close: Apr 28, 2026, 4:00 PM EDT
222.15
+0.07 (0.03%)
After-hours: Apr 28, 2026, 5:54 PM EDT
Ascendis Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| Debt / Equity Ratio | -5.35 | -5.35 | -8.10 | -4.42 | 1.93 | 0.12 | |
| Debt / FCF Ratio | 19.20 | 19.20 | - | - | - | - | |
| Net Debt / Equity Ratio | -1.57 | -1.57 | -2.81 | -1.68 | -0.89 | -0.77 | |
| Net Debt / EBITDA Ratio | -1.95 | -1.95 | -1.08 | -0.56 | 0.43 | 1.57 | |
| Net Debt / FCF Ratio | 5.63 | 5.63 | -0.97 | -0.52 | 0.46 | 1.55 | |
| Asset Turnover | 0.58 | 0.58 | 0.36 | 0.28 | 0.05 | 0.01 | |
| Inventory Turnover | 0.32 | 0.32 | 0.18 | 0.26 | 0.12 | - | |
| Quick Ratio | 0.72 | 0.72 | 0.81 | 0.62 | 1.06 | 7.03 | |
| Current Ratio | 1.04 | 1.04 | 1.17 | 0.95 | 1.29 | 8.03 | |
| Return on Equity (ROE) | - | - | - | -818.43% | -101.69% | -44.54% | |
| Return on Assets (ROA) | -6.86% | -6.86% | -17.38% | -29.73% | -32.29% | -27.35% | |
| Return on Capital Employed (ROCE) | -58.40% | -58.40% | -102.60% | -511.40% | -150.60% | -45.90% | |
| Buyback Yield / Dilution | -4.69% | -4.69% | -2.85% | -0.38% | -2.37% | -8.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.